Ankit Mehta

Dr. Ankit Mehta


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in Spine
Verified
Journal Article
Closed access
AMAnkit Mehta
Ankit Mehta
RBRanjith Bs Babu
Ranjith Bs Babu
IKIsaac O. Karikari
Isaac O. Karikari
BGBetsy Grunch
Betsy Grunch
VAVijay J. Agarwal
Vijay J. Agarwal
OGOren N. Gottfried
Oren N. Gottfried
Study Design. A retrospective review. Objective. The purpose of this study was to determine the role in body habitus and weight distribution on developing a surgical site infection (SSI). Summary of Background Data. SSI after lumbar spine surgery remains a significant cause of morbidity. The literature demonstrates an increased risk of postoperative infections associated with obesity, diabetes, and multilevel surgeries. Methods. A retrospective review was performed on a consecutive cohort of 298 adult patients who underwent lumbar spine fusion surgeries between 2006 and 2008 at the Duke University Medical Center. Previously identified risk factors (i.e., number of levels, diabetes, body mass index [BMI]) were collected, as well as the horizontal distance from the lamina to the skin surface (measured at L4) and thickness of subcutaneous fat at the surgical site. Results. Among the 298 patients, 24 (8%) had postoperative infections. Of the previously identified risk factors, number of levels (P = 0.0078) was found to be significantly associated with infections, whereas BMI (P = 0.16) and diabetes (P = 0.13) were found not to be statistically significant. Obesity (BMI ≥30) (P = 0.025), skin to lamina distance (P = 0.046), and thickness of the subcutaneous fat (P = 0.035) were found to be significant risk factors for SSI. Conclusion. Our findings suggest that in obese patients, the distribution of body mass is more predictive of SSI than the absolute BMI and deserves attention in preoperative evaluation.

1 May 2013 in Cancer Treatment Reviews
Verified
Journal Article
Closed access
AMAnkit Mehta
Ankit Mehta
ABAdam Brufsky
Adam Brufsky
JSJohn H. Sampson
John H. Sampson

1 June 2012 in Journal of Spinal Disorders & Techniques
Verified
Journal Article
Closed access
AMAnkit Mehta
Ankit Mehta
CMCindy A. Mohrhaus
Cindy A. Mohrhaus
AHAatif M. Husain
Aatif M. Husain
IKIsaac O. Karikari
Isaac O. Karikari
BHBetsy Hughes
Betsy Hughes
CBCarlos A. Bagley
Carlos A. Bagley
Retrospective cohort study and technical report. To demonstrate, through our institutional series of intramedullary spinal tumor resection, the potential avoidance of dorsal column dysfunction after using dorsal column mapping. Surgical resection of intramedullary spinal cord tumors carries significant associated postoperative morbidity. Much of this morbidity is because of dorsal column dysfunction from the dorsal myelotomy. The inconsistency and distortion of anatomic landmarks for a midline myelotomy has posed a significant challenge for spine surgeons. Dorsal column mapping is a relative new technique that may decrease the morbidity associated with operative resection of intramedullary masses. A cohort of patients operated upon at our institution for intramedullary lesions were retrospectively reviewed. Neurologic examination changes were assessed through clinic notes and chart review. A total of 91 intramedullary tumors were assessed, with 80 patients without dorsal column mapping and 11 patients with dorsal column mapping. In our cohort of 91 patients with intramedullary tumors undergoing resection over the past decade, postoperative dorsal column dysfunction was observed in 45%. Dorsal column mapping decreased the frequency of new postoperative posterior column dysfunction. Patients with dorsal column mapping had a statistically significant decrease rate of new postoperative posterior column dysfunction of 9% compared with 50% for without mapping (P=0.01). Tumor histology was not found to correlate with worsening posterior column dysfunction in patients undergoing tumor resection. With our surgical cohort as an internal control, we found a decreased rate of postoperative posterior column dysfunction when using intraoperative dorsal column mapping. Our findings show the ability of this evolving technology to provide useful intraoperative information to localize the physiological midline and decrease the rate of posterior column dysfunction after intramedullary spinal cord tumor resection.

2 October 2012 in Current Drug Discovery Technologies
Verified
Journal Article
Closed access
PDF file
AMAnkit Mehta
Ankit Mehta
BCBryan D. Choi
Bryan D. Choi
DADivya Ajay
Divya Ajay
RRRaghu Raghavan
Raghu Raghavan
MBMartin Brady
Martin Brady
JSJohn H. Sampson
John H. Sampson
The blood brain barrier (BBB) poses a significant challenge for drug delivery of macromolecules into the brain. Convection-enhanced delivery (CED) circumvents the BBB through direct intracerebral infusion using a hydrostatic pressure gradient to transfer therapeutic compounds. The efficacy of CED is dependent on the distribution of the therapeutic agent to the targeted region. Here we present a review of convection enhanced delivery of macromolecules, emphasizing the role of tracers in enabling effective delivery anddiscuss current challenges in the field.

15 March 2011 in Toxins
Verified
Journal Article
Open access
PDF file
AMAnkit Mehta
Ankit Mehta
CKCharles W. Kanaly
Charles W. Kanaly
AFAllan H. Friedman
Allan H. Friedman
DBDarell D. Bigner
Darell D. Bigner
JSJohn H. Sampson
John H. Sampson
Determining radiographic progression in primary malignant brain tumors has posed a significant challenge to the neuroncology community. Glioblastoma multiforme (GBM, WHO Grade IV) through its inherent heterogeneous enhancement, growth patterns, and irregular nature has been difficult to assess for progression. Our ability to detect tumor progression radiographically remains inadequate. Despite the advanced imaging techniques, detecting tumor progression continues to be a clinical challenge. Here we review the different criteria used to detect tumor progression, and highlight the inherent challenges with detection of progression.

15 March 2011 in Toxins
Verified
Journal Article
Open access
PDF file
AMAnkit Mehta
Ankit Mehta
BCBryan D. Choi
Bryan D. Choi
RRRaghu Raghavan
Raghu Raghavan
MBMartin Brady
Martin Brady
AFAllan H. Friedman
Allan H. Friedman
JSJohn H. Sampson
John H. Sampson
Drug delivery of immunotoxins to brain tumors circumventing the blood brain barrier is a significant challenge. Convection-enhanced delivery (CED) circumvents the blood brain barrier through direct intracerebral application using a hydrostatic pressure gradient to percolate therapeutic compounds throughout the interstitial spaces of infiltrated brain and tumors. The efficacy of CED is determined through the distribution of the therapeutic agent to the targeted region. The vast majority of patients fail to receive a significant amount of coverage of the area at risk for tumor recurrence. Understanding this challenge, it is surprising that so little work has been done to monitor the delivery of therapeutic agents using this novel approach. Here we present a review of imaging in convection enhanced delivery monitoring of toxins in humans, and discuss future challenges in the field.